The technology that gets you to Phase 2 probably won't get you to market. Small life sciences orgs face an impossible choice:  A) Invest in enterprise systems before they have enterprise needs Or: B) Stay lean and plan for a challenging migration later There's a third option most companies miss. C) Build with intentional flexibility:    - Platforms that can handle 50 patients today and evolve to 5,000 tomorrow  - Data structures that don't need rebuilding when you add new sites  - Integrations that absorb new systems without breaking existing ones We've watched companies scale from 20 employees to 200 without touching their core infrastructure. Growth and success shouldn’t force you to start over. #expertisedelivered  #lifesciences  #slipstream  

To view or add a comment, sign in

Explore content categories